Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine
Sponsor: Muhammad Aamir Latif
Summary
Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.
Official title: Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine Using the PedMIDAS Measuring Tool.
Key Details
Gender
All
Age Range
8 Years - 15 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2025-09-01
Completion Date
2026-02-28
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Flunarizine
Patients will be receiving flunarizine beginning with 5 mg at bedtime and increasing it to 10 mg at bedtime after 1 month, over a 3-month treatment period.
Propranolol
Patient will be given propranolol beginning with 10 mg/24 hours and increase at the rate of 10 mg/week to the maximum of 60 mg/24 hour, over a 3-month treatment period.
Locations (1)
The Children's Hospital Lahore
Lahore, Punjab Province, Pakistan